[Retracted] Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population

Table 4

Haplotype distribution of SLC15A1, UGT1A3, and CWC27 genes in the control group and BCa patient group.

Gene	Haplotype	Cases	Controls	OR (95% CI)
SLC15A1	C-C-C	357 (36.6%)	523 (0.464)	0.667 (0.559–0.794)	0.001
	C-C-T	173 (17.7%)	230 (20.4%)	0.841 (0.675–1.047)	0.122
	C-G-C	174 (17.8%)	100 (8.8%)	2.231 (1.715–2.902)	0.001
	T-C-C	179 (18.3)	207 (18.3)	0.999 (0.801–1.247)	0.997
UGT1A3	T-T-C	414 (42.5%)	530 (47.0%)	0.831 (0.699–0.988)	0.036
	C-T-C	235 (24.1%)	259 (23.0%)	1.064 (0.869–1.302)	0.544
	T-T-T	156 (16.0)	166 (14.7%)	1.102 (0.869–1.398)	0.419
	T-C-C	98 (10.0%	106 (9.4%)	1.076 (0.806–1.437)	0.617
CWC27	G-G-C-T	223 (22.8%)	302 (26.8%)	0.810 (0.664–0.988)	0.038
	G-C-C-C	168 (17.2%)	227 (20.1%)	0.825 (0.661–1.029)	0.088
	G-G-C-C	121 (12.4%)	138 (12.2%)	1.015 (0.782–1.318)	0.907
	G-C-C-T	109 (11.1%)	141 (12.5%)	0.880 (0.674–1.148)	0.347
	T-C-C-C	79 (8.1%)	84 (7.4%)	1.094 (0.795–1.507)	0.578